-
Solar Fridges and Powdered Vaccines: How To Get a COVID-19 Vaccine To the Developing World
UNICEF is building a global network of fridges and cold rooms—the cold chain—to make sure a vaccine stays effective as it’s transported to rural communities off the grid.
- Categories
- Coronavirus, Energy, Technology
- Region
- Sub-Saharan Africa
- Tags
- supply chains, vaccines
-
COVID-19 and Higher Education: How Universities Are Leading the Recovery in Emerging Economies
Universities in emerging economies have shown they have a key role to play in the response to the coronavirus crisis, through both cutting-edge research and development (R&D) and pioneering approaches to teaching and studying.
- Categories
- Coronavirus, Education, Health Care
-
Analysis: How Polio Eradication in Africa Can Inform the Global COVID-19 Response
The global health community recently celebrated the eradication of wild poliovirus from the African continent.
- Categories
- Coronavirus, Health Care
- Region
- Sub-Saharan Africa
-
Africa Declared Free of Wild Polio in ‘Milestone’
Africa has been declared free from wild polio by the independent body, the Africa Regional Certification Commission.
- Categories
- Health Care
-
Race for a COVID-19 Vaccine: Will Emerging Economies Be Left Behind?
As various countries contend with a second wave of Covid-19 outbreaks, many emerging markets are pinning their hopes on a vaccine that will allow them to confidently reopen their economies without the fear of health services being overwhelmed.
- Categories
- Coronavirus, Health Care
-
Bill Gates Is Spending $150 Million to Try to Make a Coronavirus Vaccine as Cheap as $3
Pay more attention to what Gates is doing overseas than what he’s saying about the United States.
- Categories
- Coronavirus, Health Care, Investing
- Tags
- impact investing, vaccines
-
Global COVID-19 Impact on Vaccines & Drugs Market Growth Is Mainly Attributed Due to Growing Number of People Infected With COVID-19 and Rising Funding for Vaccine Development – PMI
Technological advancements in the pharmaceutical sector comprising the development of nucleic acid vaccines that are DNA- and RNA-based, and which allow the human body to produce vaccine antigen. Such initiatives and activities are expected to support market growth to a substantial extent.
- Categories
- Coronavirus, Technology
- Tags
- vaccines
-
Viewpoint: Why Tech Didn’t Save Us From COVID-19
America's paralysis reveals a deep and fundamental flaw in how the nation thinks about innovation.
- Categories
- Coronavirus, Finance, Health Care, Technology
Subscribe to Our Weekly Newsletter, "NextBillion Notes"
Published each Wednesday, our e-newsletter features NextBillion's latest original articles, along with a selection of news, jobs, bizdev opportunities and events from our recent coverage — and regular conference ticket giveaways.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.